Application of Failure Mode and Effect Analysis (FMEA) to improve medication safety: a systematic review

Jayaweera A Lakshika Anjalee1, Victoria Rutter2, Nithushi R Samaranayake3

  • 1Department of Pharmacy, Colombo South Teaching Hospital, Dehiwala, Sri Lanka.

Insights

Failure Mode and Effect Analysis (FMEA) is an effective group activity for identifying medication safety errors in healthcare systems. While time-consuming and subjective, this prospective method helps improve patient safety by analyzing systems and policies.

Area of Science:

  • Healthcare Management
  • Patient Safety
  • Risk Management

Background:

  • Medication safety is a critical concern in global healthcare.
  • Prospective methods are essential for identifying potential failures in medication use.
  • Failure Mode and Effect Analysis (FMEA) is a recognized technique for proactive risk assessment.

Purpose of the Study:

  • To systematically review the application of FMEA in enhancing medication safety.
  • To analyze how FMEA is utilized within the medication use process.
  • To identify the effectiveness and limitations of FMEA in healthcare settings.

Main Methods:

  • Systematic literature review of electronic databases.
  • Keywords used: (failure mode and effect analysis) AND (pharmacy OR hospital).
  • Inclusion criteria applied, with independent screening by two researchers; cited articles were also included.

Main Results:

  • 33 articles were analyzed after initial screening of 27,706 articles.
  • FMEA was applied to both existing systems and new policies prior to implementation.
  • Participants found FMEA effective for error identification but noted it was time-consuming and subjective.

Conclusions:

  • FMEA is a valuable group activity for proactively identifying medication errors.
  • The application of FMEA contributes to improving medication safety processes.
  • Addressing the time and subjectivity challenges can further optimize FMEA's utility.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
141
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
77
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
165
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
112